Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating Lymphocytes
Condition(s):Parkinson’s Disease; Amyotrophic Lateral Sclerosis; Oxidative Stress; Iron OverloadLast Updated:March 27, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson’s Disease; Amyotrophic Lateral Sclerosis; Oxidative Stress; Iron OverloadLast Updated:March 27, 2020Completed
Condition(s):Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)Last Updated:August 12, 2008Completed
Condition(s):Anemia; Leukemia, T-Cell; Lymphocytosis; Neutropenia; ThrombocytopeniaLast Updated:July 17, 2006Completed
Condition(s):Graves DiseaseLast Updated:August 7, 2014Unknown status
Condition(s):Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell NeoplasmLast Updated:June 6, 2012Completed
Condition(s):Graft Versus Host Disease; Nonneoplastic ConditionLast Updated:August 26, 2013Unknown status
Condition(s):Ventilator-associated Pneumonia (VAP)Last Updated:February 8, 2022Suspended
Condition(s):Inflammatory Bowel DiseaseLast Updated:June 24, 2016Unknown status
Condition(s):Chronic Myelogenous Leukemia; Multiple Myeloma; Non Hodgkin’s Lymphoma; Hodgkin’s Disease; Chronic Lymphocytic LeukemiaLast Updated:August 23, 2012Terminated
Condition(s):Idiopathic Parkinson’s DiseaseLast Updated:April 4, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.